Chronic Bronchiolitis or Resistant Asthma?

This study has been completed.

First Received: August 22, 2006 Last Updated: February 17, 2009 History of Changes

Sponsor:	Baqiyatallah Medical Sciences University
Information provided by:	Baqiyatallah Medical Sciences University
ClinicalTrials.gov Identifier:	NCT00368342

Purpose

Chronic Bronchiolitis or Resistant Asthma? Testing a way to diagnosis and treatment

Condition	Intervention	Phase
Asthma	Drug: Erythromycin, Azithromycin , Clarithromycin	Phase IV

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment

Resource links provided by NLM:

MedlinePlus related topics: Asthma

Drug Information available for: Erythromycin Gluceptate Clarithromycin Azithromycin Erythromycin Erythromycin stearate Erythromycin ethylsuccinate Erythromycin estolate

U.S. FDA Resources

Eligibility

Genders Eligible for Study:

Both

Criteria

Inclusion Criteria:

Difficult asthma

Exclusion Criteria:

Patients with potential allergic bronchopulmonary aspergillosis i.e. with peripheral blood eosinophilia, sputum eosinophilia, or any sputum production and bronchiectasis
A history of smoking
Significant occupational or environmental exposures
Evidence on emphysema on chest high resolution computed tomography (HRCT) scan

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00368342

Sponsors and Collaborators

Baqiyatallah Medical Sciences University

Investigators

Principal Investigator:

Mostafa Ghanei, Prof

Research Center of Chemical Injuries, Baqyatallah Medical Sciences University, Tehran, Iran

More Information

No publications provided

Study ID Numbers:	S-340-14-6-1-PU-79
Study First Received:	August 22, 2006
Last Updated:	February 17, 2009
ClinicalTrials.gov Identifier:	NCT00368342 History of Changes
Health Authority:	Iran: Ethics Committee

Additional relevant MeSH terms:

Anti-Infective Agents
Molecular Mechanisms of Pharmacological Action
Bronchial Diseases
Immune System Diseases
Gastrointestinal Agents
Asthma
Enzyme Inhibitors
Erythromycin
Pharmacologic Actions
Anti-Bacterial Agents

Protein Synthesis Inhibitors
Clarithromycin
Lung Diseases, Obstructive
Hypersensitivity
Respiratory Tract Diseases
Therapeutic Uses
Lung Diseases
Azithromycin
Hypersensitivity, Immediate
Respiratory Hypersensitivity

ClinicalTrials.gov processed this record on February 08, 2010